Avadel Pharmaceuticals plc - ADR

NASDAQ:AVDL  
8.23
+0.35 (+4.44%)
Earnings Announcements

Avadel Pharmaceuticals Provides Corporate Update And Reports Q4 And Full Year 2020 Financial Results

Published: 03/09/2021 12:50 GMT
Avadel Pharmaceuticals plc - ADR (AVDL) - Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results.
Q4 Loss per Share $0.19.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.31

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.32

More details on our Analysts Page.